FMC Corporation Reports Q2 2026 Results with Adjusted EBITDA Above Guidance Range
FMC Corporation (NYSE: FMC) reported second quarter 2026 results showing revenue of $867 million, a decline of 17% compared to the same period in 2025. Revenue excluding India was $841 million, down 20%. The company's GAAP net loss widened significantly due to lower sales and higher restructuring costs. Despite these challenges, FMC reported Adjusted EBITDA of $153 million, which exceeded expectations at the high end of its guidance range. The firm revised its full-year outlook in response to a more challenging macroeconomic environment. It now expects revenue excluding India between $3.50 billion and $3.70 billion for 2026—a midpoint decline of about 7% from 2025 projections—and adjusted EBITDA within the range of $620 million to $680 million, a drop of approximately 23%. Free cash flow is projected between $75 million and $225 million for the year. FMC's CEO emphasized that recent strategic actions have strengthened its financial foundation. The company remains focused on improving competitiveness through innovation in active ingredients like Cyazypyr® and Rynaxypyr®, while addressing reduced demand from core legacy products.
Tickers: $FMC
Topics: adjusted earnings per share full-year outlook net loss revenue